日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial

司美格鲁肽治疗精神分裂症谱系障碍患者早期代谢异常:一项随机临床试验

Sass, Marie R; Klausen, Mette Kruse; Schwarz, Christine R; Rasmussen, Line; Giver, Malte E B; Hviid, Malthe; Schilling, Christoffer; Zamorski, Alexandra; Jensen, Andreas; Gefke, Maria; Storgaard, Heidi; Oturai, Peter S; Kjaer, Andreas; Hartmann, Bolette; Holst, Jens J; Ekstrøm, Claus T; Vinberg, Maj; Correll, Christoph U; Vilsbøll, Tina; Fink-Jensen, Anders

Large-Scale Integration of Experimental and Computational Data for 2D Materials

二维材料实验和计算数据的大规模整合

Akhound, M Amin; Boland, Tara M; Sauer, Mikkel O; Batzill, Matthias; Abraham, B Moses; Canulescu, Stela; Gogotsi, Yury; Hofmann, Philip; Kis, Andras; Lu, Jiong; Michely, Thomas; Raza, Søren; Ren, Wencai; Robinson, Joshua A; Sofer, Zdenek; Teng, Jinghua; Ulstrup, Søren; Zhao, Meng; Zhao, Xiaoxu; Mortensen, Jens J; Olsen, Thomas; Thygesen, Kristian S

Microbial activation of the GLP-2R mitigates gastrointestinal inflammation.

微生物激活 GLP-2R 可减轻胃肠道炎症。

Yang-Jensen Sune K, Choi Béatrice S-Y, Nägele Nora S, Pærregaard Simone I, Neven Kobe, Savickas Vytautas, Gupta Nazuk, Modvig Ida M, Holm Jacob B, Kristiansen Karsten, Kissow Hannelouise, Holst Jens J, Hartmann Bolette, Jensen Benjamin A H

Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists

肽基甘氨酸α-酰胺化单加氧酶中的2型糖尿病风险等位基因会影响GLP-1水平和对GLP-1受体激动剂的反应。

Umapathysivam, Mahesh M; Araldi, Elisa; Hastoy, Benoit; Dawed, Adem Y; Vatandaslar, Hasan; Mayrhofer, Johanna E; Lindquist, Peter; Silva, Pamuditha N; Goga, Algera; Trüllinger, Geraldine O; Godbersen, Svenja; Sengupta, Shahana; Kaufmann, Adrian; Thomsen, Søren Krogsgaard; Hartmann, Bolette; Chen, Yi-Chun; Jonsson, Anna E; Kabakci, Hasan; Thaman, Swaraj; Grarup, Niels; Have, Christian T; Pallo, Lindsay P; Faerch, Kristine; Gjesing, Anette P; Nawaz, Sameena; Cheeseman, Jane; Neville, Matthew J; Pedersen, Oluf; Walker, Mark; Sun, Han; Jennison, Christopher; Hattersley, Andrew T; Rehfeld, Jens F; Holman, Rury R; Verchere, Bruce C; Hansen, Torben; Karpe, Fredrik; Holst, Jens J; Rosenkilde, Mette M; Jones, Angus G; Ristow, Michael; McCarthy, Mark I; Pearson, Ewan R; Stoffel, Markus; Gloyn, Anna L

Effects of a slowly fermentable fiber mixture against the background of a high-protein diet on insulin sensitivity and metabolic health in individuals with overweight: a randomized, placebo-controlled trial

一项随机、安慰剂对照试验研究了在高蛋白饮食背景下,缓慢发酵纤维混合物对超重人群胰岛素敏感性和代谢健康的影响。

van Kalkeren, Colin A J; van Deuren, Thirza; Coenjaerds, Miranda M J; Galazzo, Gianluca; Barnett, David J M; Penders, John; Hartmann, Bolette; Holst, Jens J; Canfora, Emanuel E; Blaak, Ellen E

Empagliflozin improves beta cell function independently of relief of glucotoxicity in patients with type 2 diabetes: results from a randomised cross-over study with insulin as comparator

恩格列净可改善 2 型糖尿病患者的 β 细胞功能,且与缓解葡萄糖毒性无关:一项以胰岛素为对照的随机交叉研究结果

Thirumathyam, Roopameera; Richter, Erik A; van Hall, Gerrit; Andersen, Nicoline R; Madsen, Per L; Holst, Jens J; Madsbad, Sten; Jørgensen, Nils B

Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial

达匹鲁肽(一种双重 GLP-1 和 GLP-2 受体激动剂)治疗肥胖症:一项随机、双盲、安慰剂对照、平行组的概念验证试验

Nielsen, Casper K; Pálsson, Thorir G; Forman, Julie L; Lukacova, Michaela; Jensen, Benjamin A H; Mathiesen, David S; Englund, Anders; Gether, Ida M; Johansen, Nicklas J; Pedersen, Miriam G; Hartmann, Bolette; Holst, Jens J; Knop, Filip K; Lund, Asger B

GLP-1 Receptor Agonists for the Prevention of New-Onset Heart Failure: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials

GLP-1受体激动剂预防新发心力衰竭:安慰剂对照随机临床试验的系统评价和荟萃分析

Neves, João Sérgio; Lobato, Carolina B; Leite, Ana Rita; Vale, Catarina; Vasques-Nóvoa, Francisco; Saraiva, Francisca; Leite-Moreira, Adelino; Holst, Jens J; Ferreira, João Pedro

Spatially diffuse cAMP signalling with oppositely biased GLP-1 receptor agonists in β-cells despite differences in receptor localisation

尽管受体定位存在差异,但在β细胞中,具有相反偏向性的GLP-1受体激动剂可引起空间弥散的cAMP信号传导。

Chen, Shiqian; Lobato, Carolina B; Wong, Carissa; Manchanda, Yusman; Viloria, Katrina; Davies, Iona; Andersen, Daniel B; Ast, Julia; Sloop, Kyle W; Hodson, David J; Broichhagen, Johannes; Bloom, Steve; Holst, Jens J; Tan, Tricia; Tomas, Alejandra; Jones, Ben

Acarbose or Canagliflozin vs. Placebo to Ameliorate Post-Bariatric Hypoglycaemia: The Clinical Outcomes of the HypoBar I Randomised Clinical Trial

阿卡波糖或卡格列净与安慰剂相比,用于改善减重手术后低血糖症:HypoBar I 随机临床试验的临床结果

Lobato, Carolina B; Winding, Clara Tornøe; Bojsen-Møller, Kirstine N; Hartmann, Bolette; Martinussen, Christoffer; Veedfald, Simon; Holst, Jens J; Madsbad, Sten; Jørgensen, Nils Bruun; Dirksen, Carsten